Literature DB >> 11522442

Proteasomes and proteasome inhibition in the central nervous system.

Q Ding1, J N Keller.   

Abstract

Although the proteasome is responsible for the majority of intracellular protein degradation, and has been demonstrated to play a pivotal role in a diverse array of cellular activities, the role of the proteasome in the central nervous system is only beginning to be elucidated. Recent studies have demonstrated that proteasome inhibition occurs in numerous neurodegenerative conditions, and that proteasome inhibition is sufficient to induce neuron death, elevate intracellular levels of protein oxidation, and increase neural vulnerability to subsequent injury. The focus of this review is to describe what is currently known about proteasome biology in the central nervous system and to discuss the possible role of proteasome inhibition in the neurodegenerative process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522442     DOI: 10.1016/s0891-5849(01)00635-9

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  22 in total

1.  HIV-1 Tat-mediated neurotoxicity in retinal cells.

Authors:  Nivedita Chatterjee; Shannon Callen; Gail M Seigel; Shilpa J Buch
Journal:  J Neuroimmune Pharmacol       Date:  2011-01-28       Impact factor: 4.147

Review 2.  Oxidative neuronal injury. The dark side of ERK1/2.

Authors:  Charleen T Chu; David J Levinthal; Scott M Kulich; Elisabeth M Chalovich; Donald B DeFranco
Journal:  Eur J Biochem       Date:  2004-06

Review 3.  Comparative Microarray Analysis Identifies Commonalities in Neuronal Injury: Evidence for Oxidative Stress, Dysfunction of Calcium Signalling, and Inhibition of Autophagy-Lysosomal Pathway.

Authors:  Yann Wan Yap; Roxana M Llanos; Sharon La Fontaine; Michael A Cater; Philip M Beart; Nam Sang Cheung
Journal:  Neurochem Res       Date:  2015-08-29       Impact factor: 3.996

Review 4.  The proteasome: a central regulator of inflammation and macrophage function.

Authors:  Nilofer Qureshi; Stefanie N Vogel; Charles Van Way; Christopher J Papasian; Asaf A Qureshi; David C Morrison
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin.

Authors:  Pamela Maher
Journal:  Genes Nutr       Date:  2009-09-10       Impact factor: 5.523

Review 6.  The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors.

Authors:  Mario Di Napoli; BethAnn McLaughlin
Journal:  Curr Opin Investig Drugs       Date:  2005-07

Review 7.  Huntington's Disease.

Authors:  Steven Finkbeiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

8.  Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's disease.

Authors:  Hanoch Elkon; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Toxicological investigation and antinociceptive property of potassium thiophene-3-trifluoroborate.

Authors:  Roberta A Oliveira; Lucielli Savegnago; Cristiano R Jesse; Paulo H Menezes; Gary A Molander; Cristina W Nogueira
Journal:  Basic Clin Pharmacol Toxicol       Date:  2009-03-27       Impact factor: 4.080

Review 10.  Linkage between the proteasome pathway and neurodegenerative diseases and aging.

Authors:  Sophie Vigouroux; Marièle Briand; Yves Briand
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.